Newborn screening: toward a uniform screening panel and system.
The Maternal and Child Health Bureau commissioned the American College of Medical Genetics to outline a process for the standardization of outcomes and guidelines for state newborn screening programs and to define responsibilities for collecting and evaluating outcome data, including a recommended uniform panel of conditions to include in state newborn screening programs. The expert panel identified 29 conditions for which screening should be mandated. An additional 25 conditions were identified because they are part of the differential diagnosis of a condition in the core panel, they are clinically significant and revealed with screening technology but lack an efficacious treatment, or they represent incidental findings for which there is potential clinical significance. The process of identification is described, and recommendations are provided.
D003362:Cost-Benefit Analysis; D003937:Diagnosis, Differential; D005820:Genetic Testing / Q000379:methods* / Q000592:standards*; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000175:diagnosis; D015997:Neonatal Screening / Q000379:methods* / Q000592:standards*; D015397:Program Evaluation; D013219:State Government; D014481:United States